Compare MESO & NBHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MESO | NBHC |
|---|---|---|
| Founded | 2004 | 2009 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 2005 | 2011 |
| Metric | MESO | NBHC |
|---|---|---|
| Price | $11.96 | $37.53 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | $37.00 | ★ $44.00 |
| AVG Volume (30 Days) | 216.6K | ★ 446.7K |
| Earning Date | 08-26-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 3.38% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.04 |
| Revenue | N/A | ★ $47,100,000.00 |
| Revenue This Year | $59.17 | $25.73 |
| Revenue Next Year | $59.00 | $7.50 |
| P/E Ratio | ★ N/A | $36.41 |
| Revenue Growth | N/A | ★ 2.86 |
| 52 Week Low | $12.94 | $35.06 |
| 52 Week High | $21.50 | $47.28 |
| Indicator | MESO | NBHC |
|---|---|---|
| Relative Strength Index (RSI) | 28.02 | 33.96 |
| Support Level | N/A | $37.43 |
| Resistance Level | $15.97 | $42.66 |
| Average True Range (ATR) | 0.40 | 0.67 |
| MACD | -0.12 | 0.03 |
| Stochastic Oscillator | 2.03 | 29.80 |
Mesoblast Ltd is a commercial-stage biotechnology company engaged in developing and commercializing allogeneic (off-the-shelf) cellular medicines for severe inflammatory conditions. Its commercial product, Ryoncil (remestemcel-L-rknd), is FDA-approved for steroid-refractory acute graft-versus-host disease in pediatric patients. The company is also developing Ryoncil for additional inflammatory indications. Its rexlemestrocel-L platform is being developed for chronic low back pain associated with degenerative disc disease and chronic heart failure. The company operates as a single segment focused on its allogeneic cellular medicines platform.
National Bank Holdings Corp offers a full range of banking products and financial services to commercial, business, and consumer clients predominantly in Colorado, with a focus on personalized service through relationship managers and banking center associates. The company provides commercial and industrial loans, non-owner occupied commercial real estate loans, Small Business Administration loans as a Preferred Lender Provider, U.S. Department of Agriculture and Farm Service Agency loans, commercial deposit and treasury management products, business online and mobile banking, consumer and residential real estate loans, deposit services, and trust and wealth management services. Its services emphasize full-relationship banking, integrating lending, deposits, and cash management solutions.